Transcervical intrauterine radiofrequency ablation of fibroids in high-risk patients with bleeding disorder.
Ginekol Pol
; 93(8): 614-619, 2022.
Article
in En
| MEDLINE
| ID: mdl-35894488
ABSTRACT
OBJECTIVES:
To show the advantages of transcervical radiofrequency ablation (TRFA) in high-risk patients with bleeding disorder. MATERIAL ANDMETHODS:
It is a retrospective analysis. The study included only patients with known pre-existing conditions (obesity, cardiac and neurological disease, coagulation disorder, anaemia) or post-surgical conditions who were treated with the Sonata® System for fibroid-related bleeding complaints at Academic Hospital Cologne Weyertal between January 2015 and March 2021. These patients were classified as high-risk patients. The fibroids were mostly determined due transvaginal sonography. Thirty patients were included, and 43 fibroids were determined.RESULTS:
Therapy with the Sonata® system could be performed without complications in all cases. In our analysis, improvement of fibroid-related symptoms was observed in 89% of cases.CONCLUSIONS:
The Sonata® System is on the one hand minimally invasive, uncomplicated and fast and on the other hand a successful method of fibroid therapy, which is particularly suitable for high-risk patients with various pre-existing conditions, for whom a minimally invasive, bloodless and short surgical procedure has great advantages.Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Uterine Neoplasms
/
Blood Coagulation Disorders
/
Radiofrequency Ablation
/
Leiomyoma
Type of study:
Etiology_studies
/
Observational_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
Language:
En
Journal:
Ginekol Pol
Year:
2022
Document type:
Article
Affiliation country:
Publication country:
PL
/
POLAND
/
POLONIA
/
POLÔNIA